Unione Europea -
norvegese -
EMA (European Medicines Agency)
bropair spiromax
teva b.v. - salmeterol xinafoate, fluticasone propionate - astma - legemidler for obstruktive sykdommer i luftveiene, - bropair spiromax is indicated in the regular treatment of asthma in adults and adolescents aged 12 years and older not adequately controlled with inhaled corticosteroids and ‘as needed’ inhaled short-acting β₂ agonists.
Unione Europea -
norvegese -
EMA (European Medicines Agency)
seffalair spiromax
teva b.v. - fluticasone propionate, salmeterol xinafoate - astma - legemidler for obstruktive sykdommer i luftveiene, - seffalair spiromax is indicated in the regular treatment of asthma in adults and adolescents aged 12 years and older not adequately controlled with inhaled corticosteroids and ‘as needed’ inhaled short-acting β₂ agonists.
Unione Europea -
norvegese -
EMA (European Medicines Agency)
riltrava aerosphere
astrazeneca ab - budesonide, formoterol fumarate dihydrate, glycopyrronium bromide - lungesykdom, kronisk obstruktiv - legemidler for obstruktive sykdommer i luftveiene, - riltrava aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2 agonist or combination of a long-acting beta2 agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5.
Unione Europea -
norvegese -
EMA (European Medicines Agency)
tezspire
astrazeneca ab - tezepelumab - astma - legemidler for obstruktive sykdommer i luftveiene, - tezspire is indicated as an add-on maintenance treatment in adults and adolescents 12 years and older with severe asthma who are inadequately controlled despite high dose inhaled corticosteroids plus another medicinal product for maintenance treatment.
Norvegia -
norvegese -
Statens legemiddelverk
otisur
chanelle pharmaceuticals manufacturing ltd - mikonazolnitrat / prednisolonacetat / polymyksin b sulfat - Øredråper, suspensjon - 23 mg/ ml / 5 mg/ ml / 5500 ie/ ml
Unione Europea -
norvegese -
EMA (European Medicines Agency)
arikayce liposomal
insmed netherlands b.v. - amikacin sulfate - luftveisinfeksjoner - antibakterielle midler for systemisk bruk, - arikayce liposomal is indicated for the treatment of non-tuberculous mycobacterial (ntm) lung infections caused by mycobacterium avium complex (mac) in adults with limited treatment options who do not have cystic fibrosis.
Norvegia -
norvegese -
Statens legemiddelverk
nurofen 40 mg/ ml
reckitt benckiser healthcare (scandinavia) a/s (1) - ibuprofen - mikstur, suspensjon med jordbærsmak - 40 mg/ ml
Norvegia -
norvegese -
Statens legemiddelverk
nurofen 40 mg/ ml
reckitt benckiser healthcare (scandinavia) a/s (1) - ibuprofen - mikstur, suspensjon med appelsinsmak - 40 mg/ ml
Unione Europea -
norvegese -
EMA (European Medicines Agency)
insulin human winthrop
sanofi-aventis deutschland gmbh - insulin human - sukkersyke - legemidler som brukes i diabetes - diabetes mellitus hvor behandling med insulin er nødvendig. insulin human winthrop rapid er også egnet for behandling av hyperglykemisk koma og ketoacidose, samt for å oppnå pre-, intra- og postoperativ stabilisering hos pasienter med diabetes mellitus.